Assignee
BAXTER AG
AT·70 granted patents·3 pending applications·2,340 citations·filing 1992–2008
Top patents by PatentIndex Score
73 records- 0199US6936441B2Recombinant cell clones having increased stability and methods of making and using the sameBAXTER AG·Filed 2002·Granted Aug 30, 2005·160 cites·27 claims
- 0297US7094574B2Recombinant cell clones having increased stability and methods of making and using the sameBAXTER AG·Filed 2005·Granted Aug 22, 2006·32 cites·10 claims
- 0397US6620125B1Method and device for mixing and applying components of differing viscositiesBAXTER AG·Filed 2000·Granted Sep 16, 2003·104 cites·14 claims
- 0497US6224862B1Pharmaceutical preparation for treating blood coagulation disordersBAXTER AG·Filed 2000·Granted May 1, 2001·88 cites·4 claims
- 0596US6475725B1Recombinant cell clones having increased stability and methods of making and using the sameBAXTER AG·Filed 1999·Granted Nov 5, 2002·119 cites·34 claims
- 0695US7033590B1Factor IX/factor IXa activating antibodies and antibody derivativesBAXTER AG·Filed 2000·Granted Apr 25, 2006·47 cites·22 claims
- 0793US6316226B1Proteins with Factor VIII activity: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing themBAXTER AG·Filed 1995·Granted Nov 13, 2001·143 cites·8 claims
- 0892US6372223B1Influenza virus vaccine compositionBAXTER AG·Filed 1999·Granted Apr 16, 2002·101 cites·8 claims
- 0991US6926894B2Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLVBAXTER AG·Filed 2001·Granted Aug 9, 2005·39 cites·27 claims
- 1091US6146873AProduction of orthomyxoviruses in monkey kidney cells using protein-free mediaBAXTER AG·Filed 1997·Granted Nov 14, 2000·158 cites·37 claims
- 1190US7279161B2Factor IX/factor IXa activating antibodies and antibody derivativesBAXTER AG·Filed 2005·Granted Oct 9, 2007·6 cites·9 claims
- 1290US6228613B1Stable factor VIII/von Willebrand factor complexBAXTER AG·Filed 1997·Granted May 8, 2001·53 cites·40 claims
- 1389US7220569B2Nucleic acids encoding factor X analogues having a modified protease cleavage siteBAXTER AG·Filed 2003·Granted May 22, 2007·37 cites·16 claims
- 1489US6013620APharmaceutical composition for the treatment of blood coagulation diseases, methods for the production thereof and its useBAXTER AG·Filed 1997·Granted Jan 11, 2000·79 cites·25 claims
- 1588US7241603B2Method for producing a preparation based on fibrinogen and fibronectin as well as protein compositions obtainable according to this methodBAXTER AG·Filed 2002·Granted Jul 10, 2007·25 cites·8 claims
- 1688US6596526B1Furin polypeptides with improved characteristicsBAXTER AG·Filed 2000·Granted Jul 22, 2003·20 cites·15 claims
- 1788US6017891AStable preparation for the treatment of blood coagulation disordersBAXTER AG·Filed 1997·Granted Jan 25, 2000·78 cites·27 claims
- 1886US6114146AExpression plasmid, a fusion protein, a transfected eukaryotic cell line, a method of producing foreign proteins, a foreign protein preparation as well as a pharmaceutical compositionBAXTER AG·Filed 1995·Granted Sep 5, 2000·94 cites·31 claims
- 1985US7892802B2Fibrinogen-based tissue adhesive containing an elastase inhibitorBAXTER AG·Filed 2008·Granted Feb 22, 2011·7 cites·23 claims
- 2085US6958322B1Factor X analog with an improved ability to be activatedBAXTER AG·Filed 2000·Granted Oct 25, 2005·18 cites·29 claims
- 2185US6579537B2Method for producing fibronectin and fibrinogen compositions using a polyalkylene glycol and glycine or β-alanineBAXTER AG·Filed 2000·Granted Jun 17, 2003·27 cites·18 claims
- 2283US7459295B2Fibrinogen-based tissue adhesive containing an elastase inhibitorBAXTER AG·Filed 2006·Granted Dec 2, 2008·7 cites·12 claims
- 2383US6210929B1Fusion protein comprising a furin derivative or a derivative of a furin analogue and a heterologous sequenceBAXTER AG·Filed 1996·Granted Apr 3, 2001·43 cites·22 claims
- 2482US6905846B2Nucleic acids encoding factor X deletion mutants and analogues thereofBAXTER AG·Filed 2003·Granted Jun 14, 2005·15 cites·17 claims
- 2581US6953837B2Factor VIII/vWF complexes and compositionsBAXTER AG·Filed 2001·Granted Oct 11, 2005·12 cites·6 claims
- 2681US6670116B2Methods for the detection, quantification and differentiation of infectious versus non-infectious pathogens in a sampleBAXTER AG·Filed 2000·Granted Dec 30, 2003·10 cites·25 claims
- 2781US6506365B1Fibrin/fibrinogen binding conjugateBAXTER AG·Filed 2000·Granted Jan 14, 2003·14 cites·22 claims
- 2881US6136321AMethod of inactivating lipid-enveloped virusesBAXTER AG·Filed 1998·Granted Oct 24, 2000·50 cites·16 claims
- 2980US6649162B1Hemostatic sponge based on collagenBAXTER AG·Filed 1997·Granted Nov 18, 2003·86 cites·2 claims
- 3079US6974792B2Alpha 1-antitrypsin preparation as well as a method for producing the sameBAXTER AG·Filed 2001·Granted Dec 13, 2005·24 cites·15 claims
- 3178US6924151B2Stable factor VIII/vWF-complexBAXTER AG·Filed 2001·Granted Aug 2, 2005·3 cites·13 claims
- 3278US6713453B2Fibrin/fibrinogen-binding conjugateBAXTER AG·Filed 2001·Granted Mar 30, 2004·9 cites·45 claims
- 3378US6103244AMethods for generating immune responses employing modified vaccinia of fowlpox virusesBAXTER AG·Filed 1996·Granted Aug 15, 2000·36 cites·14 claims
- 3477US6086871AProthrombin derivativesBAXTER AG·Filed 1996·Granted Jul 11, 2000·39 cites·22 claims
- 3576US6777390B1Stable blood coagulation inhibitor-free factor vii preparation and method for preparing sameBAXTER AG·Filed 1999·Granted Aug 17, 2004·29 cites·27 claims
- 3674US6103693AMethod for isolation of highly pure von willebrand factorBAXTER AG·Filed 1997·Granted Aug 15, 2000·27 cites·13 claims
- 3773US6573071B1Factor X analogues with a modified protease cleavage siteBAXTER AG·Filed 1998·Granted Jun 3, 2003·29 cites·64 claims
- 3873US6358918B1Preparation comprising thiol-group-containing proteinsBAXTER AG·Filed 2000·Granted Mar 19, 2002·7 cites·33 claims
- 3972US6562598B1Factor X deletion mutants and analogues thereofBAXTER AG·Filed 1998·Granted May 13, 2003·27 cites·56 claims
- 4070US7005502B1Pharmaceutical preparation comprising vWF propeptideBAXTER AG·Filed 1998·Granted Feb 28, 2006·24 cites·5 claims
- 4170US6358534B1Immunotolerant prothrombin complex preparationBAXTER AG·Filed 1998·Granted Mar 19, 2002·32 cites·60 claims
- 4269US6465624B1Purification of von-Willebrand factor by cation exchanger chromatographyBAXTER AG·Filed 1998·Granted Oct 15, 2002·31 cites·22 claims
- 4368US6579723B1Method of recovering highly purified vWF or factor VIII/vWF-complexBAXTER AG·Filed 1998·Granted Jun 17, 2003·34 cites·51 claims
- 4467US6265183B1Direct molecular cloning of foreign genes into poxviruses and methods for the preparation of recombinant proteinsBAXTER AG·Filed 1994·Granted Jul 24, 2001·23 cites·17 claims
- 4566US6548729B1Fibrin spongeBAXTER AG·Filed 1998·Granted Apr 15, 2003·63 cites·42 claims
- 4666US2007161079A1Recombinant cell clones having increased stability and methods of making and using the sameBAXTER AG·Filed 2006·Application pending·0 cites
- 4765US6221363B1Vaccine for the prevention of lyme diseaseBAXTER AG·Filed 1992·Granted Apr 24, 2001·15 cites·18 claims
- 4865US6039945APharmaceutical preparation for treating blood coagulation disordersBAXTER AG·Filed 1998·Granted Mar 21, 2000·13 cites·13 claims
- 4964US6099837APharmaceutical preparation for treating blood coagulation disordersBAXTER AG·Filed 1999·Granted Aug 8, 2000·12 cites·16 claims
- 5061US6165974APharmaceutical preparation for treating blood coagulation disordersBAXTER AG·Filed 1999·Granted Dec 26, 2000·10 cites·19 claims
Showing the top 50 of 73 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →